HAM-D anxiety subscale improvement
Related entities
Findings (27)
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96
None
improvementTreatment responders with depression in Parkinson's disease demonstrated significant improvement on the HAM-D anxiety subscale compared to nonresponders after 8 weeks of antidepressant treatment.
Effect: improvement; Cohen's d=.96